Frankfurt - Delayed Quote EUR
Q32 Bio Inc. (DB0.F)
1.5600
-0.0500
(-3.11%)
At close: April 25 at 3:49:30 PM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.06M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KALOWSKI LEE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
| MORRISON JODIE POPE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
| CAMPAGNA JASON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
| VIOLETTE SHELIA M PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2025 |
| VIOLETTE SHELIA M PH.D. Officer | Conversion of Exercise of derivative security at price 3.12 - 7.29 per share. | Direct | 58,011 | Oct 15, 2024 |
| VIOLETTE SHELIA M PH.D. Officer | Conversion of Exercise of derivative security at price 3.12 per share. | Direct | 41,496 | Oct 8, 2024 |
| TZIANABOS ARTHUR Director | -- | Direct | -- | Mar 25, 2024 |
| ALLOWAY PAUL President | -- | Direct | -- | Mar 25, 2024 |
| MICHAUD CHARLES JR. Officer and Treasurer | -- | Direct | -- | Mar 25, 2024 |
| TZIANABOS ARTHUR Director | Sale at price 0.05 per share. | Direct | 14 | Mar 25, 2024 |
| ALLOWAY PAUL Former | Sale at price 0.05 per share. | Direct | 14 | Mar 25, 2024 |
| MICHAUD CHARLES JR. Officer | Sale at price 0.05 per share. | Direct | 4 | Mar 25, 2024 |
| TZIANABOS ARTHUR Director | Sale at price 0.57 per share. | Direct | 7,445 | Jan 9, 2024 |
| ALLOWAY PAUL President | Sale at price 0.57 per share. | Direct | 4,120 | Jan 3, 2024 |
| MICHAUD CHARLES JR. Officer and Treasurer | Sale at price 0.57 per share. | Direct | 975 | Jan 3, 2024 |
| TZIANABOS ARTHUR Director | -- | Direct | -- | Dec 29, 2023 |
| ALLOWAY PAUL President | -- | Direct | -- | Dec 29, 2023 |
| MICHAUD CHARLES JR. Officer and Treasurer | -- | Direct | -- | Dec 29, 2023 |
| SEYMOUR ALBERT B Chief Executive Officer | -- | Direct | -- | Sep 6, 2023 |
| SEYMOUR ALBERT B Chief Executive Officer | Sale at price 1.15 per share. | Direct | 1,665 | Sep 6, 2023 |
| JORDAN JULIE Officer | -- | Direct | -- | Aug 3, 2023 |
| JORDAN JULIE Officer | Sale at price 1.39 per share. | Direct | 2,576 | Aug 3, 2023 |
| JORDAN JULIE Officer | -- | Direct | -- | Aug 2, 2023 |
| JORDAN JULIE Officer | Sale at price 1.31 per share. | Direct | 130 | Aug 2, 2023 |
Related Tickers
2509.HK Qyuns Therapeutics Co., Ltd.
10.960
+3.59%
CLYM Climb Bio, Inc.
1.2700
-2.31%
EQ Equillium, Inc.
0.4382
-4.74%
HNSA.ST Hansa Biopharma AB (publ)
28.36
+19.76%
TVRD Tvardi Therapeutics, Inc.
18.85
+5.90%
SAGE Sage Therapeutics, Inc.
7.79
0.00%
FOLD Amicus Therapeutics, Inc.
7.35
+2.08%
AVTE Aerovate Therapeutics, Inc.
2.6800
-1.47%
XFOR X4 Pharmaceuticals, Inc.
0.1900
+1.50%
ONC BeiGene, Ltd.
244.90
-4.40%